XGN
Exagen Inc

560
Mkt Cap
$217.34M
Volume
522,561.00
52W High
$12.23
52W Low
$2.67
PE Ratio
-10.36
XGN Fundamentals
Price
$9.35
Prev Close
$9.59
Open
$9.57
50D MA
$10.68
Beta
1.05
Avg. Volume
221,640.26
EPS (Annual)
-$0.8304
P/B
11.90
Rev/Employee
$266,224.88
Loading...
Loading...
News
all
press releases
BTIG Research Forecasts Strong Price Appreciation for Exagen (NASDAQ:XGN) Stock
BTIG Research increased their price objective on Exagen from $13.00 to $15.00 and gave the company a "buy" rating in a research report on Monday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Cantor Fitzgerald Forecasts Weaker Earnings for Exagen
Exagen Inc. (NASDAQ:XGN - Free Report) - Cantor Fitzgerald decreased their FY2026 earnings per share estimates for shares of Exagen in a research note issued to investors on Wednesday, November 5th...
MarketBeat·5d ago
News Placeholder
Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates
Exagen (XGN) delivered earnings and revenue surprises of -46.15% and +0.55%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates
Exagen (XGN) delivered earnings and revenue surprises of 0.00% and +7.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Exagen (XGN) Soars 5.5%: Is Further Upside Left in the Stock?
Exagen (XGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·4mo ago
News Placeholder
Q1 2024 EPS Estimates for Exagen Inc. (NASDAQ:XGN) Decreased by Analyst
Exagen Inc. (NASDAQ:XGN Free Report) William Blair reduced their Q1 2024 earnings estimates for shares of Exagen in a note issued to investors on Monday, March 18th. William Blair...
Ticker Report·2y ago
News Placeholder
Exagen (NASDAQ:XGN) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPS
Exagen (NASDAQ:XGN Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of...
Ticker Report·2y ago
News Placeholder
Q4 2023 Exagen Inc Earnings Call Transcript
Related Stocks: NAS:XGN...
GuruFocus·2y ago
News Placeholder
Exagen continues to execute on re-acceleration strategy, says Canaccord
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full...
Globe Newswire·2y ago

Latest XGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.